A comprehensive overview of a single-institutional (University College London Hospital) experience with CDK4/6 inhibitors in ER+/HER2- metastatic breast cancer

{"title":"A comprehensive overview of a single-institutional (University College London Hospital) experience with CDK4/6 inhibitors in ER+/HER2- metastatic breast cancer","authors":"T.J. Walsh, L.M. Vallodolid, K. Gayford, R. Nayar, K. DeSouza, R. Roylance","doi":"10.1016/j.clon.2024.103728","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"38 ","pages":"Article 103728"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0936655524005326","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}